Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease

Neurology. 1998 Jun;50(6):1556-62. doi: 10.1212/wnl.50.6.1556.

Abstract

Objective: To examine the genetic association of CYP2D6 locus with Lewy body variant (LBV) and Parkinson's disease (PD).

Methods: Allelic association was studied in patients with pure AD, LBV, and PD by using the CYP2D microsatellite, the (dG-dT)n dinucleotide repeat (n=16 to 27) located between CYP2D8P and CYP2D7 genes, and the CYP2D6 B and D mutations.

Results: We found overrepresentation of the alleles longer than 21 repeat (the long-type alleles) in LBV (allele frequency, 0.313) (odds ratio=1.99, p=0.019 by chi2 test) and in PD (0.298) (odds ratio=1.86, p=0.037), but not in pure AD (0.196), compared with the age-matched control (0.186). Strong association was noted of the long-type alleles with the CYP2D6 B mutation (odds ratio=88.50, p < 0.001 by Fisher's exact test), but not with the D mutation or the deletion of CYP2D6 gene.

Conclusions: The CYP2D locus is closely associated with LBV and PD. The CYP2D6 B mutation may be involved in pathogenesis of LBV and PD in a dominant-negative manner, or in the linkage disequilibrium of the CYP2D microsatellite to another pathogenic gene locus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Alleles
  • Alzheimer Disease / genetics*
  • Cytochrome P-450 CYP2D6 / genetics*
  • Genotype
  • Humans
  • Microsatellite Repeats / genetics*
  • Mutation / genetics
  • Parkinson Disease / genetics*
  • Polymorphism, Genetic / genetics*

Substances

  • Cytochrome P-450 CYP2D6